A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
Active, not recruiting · NCT01957436 · Registry updated 2024-11-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2024-11-12 | NCT01957436 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 54 |
| Ipsen | 59 |
| Janssen-Cilag Ltd. | 14 |
| Sanofi | 254 |
| UNICANCER | 111 |
77 results · Page 1 of 4
Research sites
Swipe the table sideways for more columns.